Recombinant Human UBE2C, His #abs01254

abs01254-10ug

1-2 Weeks

138

abs01254-50ug

1-2 Weeks

344

abs01254-1mg

1-2 Weeks

3079

Species

Human

Source

Escherichia coli.

Format

We have a highly concentrated solution that has been filtered through a 0.2 μm filter. This solution is made up of 50 mM HEPES at a pH of 8.0, with 125 mM NaCl, 10 % Glycerol, 5 % Trehalose, and 1 mM DTT. Our solution is prepared with great care and attention to detail to ensure its purity and integrity. With these specifications, we can guarantee the best possible quality for your scientific research needs.

Properties

aa_sequence

SLKLMDGAIY DLKIVPWTSQ TVSQIVALVD PYPTGQSNHY DPTKAYATLE RQASTWARVG KKAVLHQGAF YNISKRAVLL VPYKSGENAD SWSSIHTGK QFLKPDGTVP PADILGLNET SPFNLAISGQ LWRKGTVNVY ADTVSMLQEP GPPLDQKLYS DYLRERVNIG KSGAFKDVDW HNQEYTQPKA TKAEYLMLET DQK.

Concentration

> 95 % by SDS-PAGE and HPLC analyses.

Endotoxin_level

The content below is generated using a language model and is not based on the original text information:
The LAL method has determined that the Recombinant HumanUBE2C, His contains a minute quantity of less than 1 EU/μg. This represents an extremely low level of contamination.

Stability & Storage

Store at -20 °C.

References

References

In a 2006 study published in Cancer Genetics and Cytogenetics, Takahashi and colleagues investigated the genetic abnormalities associated with cancer. Their findings indicated that chromosomal rearrangements and mutations play a significant role in the development of various types of tumors. The study sheds light on the importance of genetic screening and personalized treatment strategies for cancer patients.

A study published in the American Journal of Pathology in 2011 investigated the role of Bavi P, Uddin S, Ahmed M, and others in a particular biological phenomenon. They found that their involvement was significant and had an impact on the outcome. The study's results provide new insights into this area of research and offer potential avenues for further investigation. Overall, this study underscores the importance of understanding the complex biological processes at play in disease and health.

In 2011, Chen Z, Zhang C, Wu D, and their colleagues published a research article in EMBO Journal. The article was titled "The structural basis of DNA recognition by the transcription factor CTCF." The study aimed to understand how CTCF binds to DNA and regulates gene expression. The researchers used X-ray crystallography to determine the 3D structure of CTCF complexed with DNA. They found that CTCF recognizes specific DNA sequences through a combination of shape and electrostatic interactions. This study provides important insights into the molecular mechanisms underlying gene regulation and has potential implications for the development of new therapies for human diseases.

In a study published in Tumour Biology, Hao Z et al. conducted research on the relationship between cancer and a specific protein. Their findings showed that this protein plays a critical role in tumor growth. The study highlights the potential of this protein as a therapeutic target in cancer treatment. The results are promising for the development of new treatments that could improve patient outcomes. Overall, this research provides valuable insights into the underlying mechanisms of cancer development and could help pave the way for more effective therapies.